Current chemotherapy regimens slow cancer progression
and save lives, but these powerful drugs affect both healthy and
cancerous cells. Now, researchers reporting in ACS’ Nano Letters
have designed DNA-based nanogels that only break down and release
their chemotherapeutic contents within cancer cells, minimizing the
impacts on normal ones and potentially eliminating painful and
uncomfortable side effects.